Systemic and Local Adipose Tissue in Knee Osteoarthritis

Journal of Cellular Physiology

Volumn 232, Issue 8, 2017, Pages 1971-1978

  Belluzzi, Elisa ^a   El Hadi, Hamza ^a   Granzotto, Marnie ^a   Rossato, Marco ^a   Ramonda, Roberta ^a   Macchi, Veronica ^b   De Caro, Raffaele ^b   Vettor, Roberto ^a   Favero, Marta ^a,c  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; CYTOKINE;

ADIPOSE TISSUE; COMORBIDITY; DYSLIPIDEMIA; FAT PAD; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; KNEE OSTEOARTHRITIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; ANIMAL; BIOMECHANICS; DIAGNOSTIC IMAGING; KNEE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS, KNEE; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; SIGNAL TRANSDUCTION;

ADIPOKINES; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BIOMECHANICAL PHENOMENA; COMORBIDITY; CYTOKINES; HUMANS; KNEE JOINT; MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOARTHRITIS, KNEE; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 85014163333     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25716     Document Type: Review

References (100)

1. Alvarez-Garcia O, Rogers NH, Smith RG, Lotz MK. 2014. Palmitate has proapoptotic and proinflammatory effects on articular cartilage and synergizes with interleukin-1. Arthritis Rheumatol 66:1779–1788.
2. Anderson JJ, Felson DT. 1988. Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol 128:179–189.
3. Bao JP, Chen WP, Feng J, Hu PF, Shi ZL, Wu LD. 2010. Leptin plays a catabolic role on articular cartilage. Mol Biol Rep 37:3265–3272.
4. Bastiaansen-Jenniskens YM, Clockaerts S, Feijt C, Zuurmond AM, Stojanovic-Susulic V, Bridts C, de Clerck L, DeGroot J, Verhaar JA, Kloppenburg M, van Osch GJ. 2012. Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage. Ann Rheum Dis 71:288–294.
5. Bastiaansen-Jenniskens YM, Wei W, Feijt C, Waarsing JH, Verhaar JA, Zuurmond AM, Hanemaaijer R, Stoop R, van Osch GJ. 2013. Stimulation of fibrotic processes by the infrapatellar fat pad in cultured synoviocytes from patients with osteoarthritis: A possible role for prostaglandin f2alpha. Arthritis Rheum 65:2070–2080.
6. Burr DB, Radin EL. 2003. Microfractures and microcracks in subchondral bone: Are they relevant to osteoarthrosis? Rheum Dis Clin N Am 29:675–685.
7. Calvet J, Orellana C, Gratacos J, Berenguer-Llergo A, Caixas A, Chillaron JJ, Pedro-Botet J, Garcia-Manrique M, Navarro N, Larrosa M. 2016. Synovial fluid adipokines are associated with clinical severity in knee osteoarthritis: A cross-sectional study in female patients with joint effusion. Arthritis Res Ther 18:207.
8. Chen TH, Chen L, Hsieh MS, Chang CP, Chou DT, Tsai SH. 2006. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 1762:711–718.
9. Chuckpaiwong B, Charles HC, Kraus VB, Guilak F, Nunley JA. 2010. Age-associated increases in the size of the infrapatellar fat pad in knee osteoarthritis as measured by 3T MRI. J Orthop Res 28:1149–1154.
10. Cimmino MA, Cutolo M. 1990. Plasma glucose concentration in symptomatic osteoarthritis: A clinical and epidemiological survey. Clin Exp Rheumatol 8:251–257.
11. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS. 2005. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355.
12. Clements KM, Ball AD, Jones HB, Brinckmann S, Read SJ, Murray F. 2009. Cellular and histopathological changes in the infrapatellar fat pad in the monoiodoacetate model of osteoarthritis pain. Osteoarthritis Cartilage 17:805–812.
13. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, Van Osch GJ, Van Offel JF, Verhaar JA, De Clerck LS, Somville J. 2010. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: A narrative review. Osteoarthritis Cartilage 18:876–882.
14. Coggon D, Reading I, Croft P, McLaren M, Barrett D, Cooper C. 2001. Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord 25:622–627.
15. Conde J, Scotece M, Abella V, Gomez R, Lopez V, Villar R, Hermida M, Pino J, Gomez-Reino JJ, Gualillo O. 2015. Identification of novel adipokines in the joint. Differential expression in healthy and osteoarthritis tissues. PLoS ONE 10:e0123601.
16. Conde J, Scotece M, Lopez V, Abella V, Hermida M, Pino J, Lago F, Gomez-Reino JJ, Gualillo O. 2014. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals. Ann Rheum Dis 73:631–633.
17. Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L. 2014. The global burden of hip and knee osteoarthritis: Estimates from the global burden of disease 2010 study. Ann Rheum Dis 73:1323–1330.
18. Cuzdan Coskun N, Ay S, Evcik FD, Oztuna D. 2015. Adiponectin: Is it a biomarker for assessing the disease severity in knee osteoarthritis patients? Int J Rheum Dis. [Epub ahead of print]. DOI: 10.1111/1756-185X.12790
19. Davis MA, Ettinger WH, Neuhaus JM. 1990. Obesity and osteoarthritis of the knee: Evidence from the national health and nutrition examination survey (NHANES I). Semin Arthritis Rheum 20:34–41.
20. de Munter W, Blom AB, Helsen MM, Walgreen B, van der Kraan PM, Joosten LA, van den Berg WB, van Lent PL. 2013. Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis. Arthritis Res Ther 15:R178.
21. Distel E, Cadoudal T, Durant S, Poignard A, Chevalier X, Benelli C. 2009. The infrapatellar fat pad in knee osteoarthritis: An important source of interleukin-6 and its soluble receptor. Arthritis Rheum 60:3374–3377.
22. Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P, Pottie P. 2003. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48:3118–3129.
23. Ebbert JO, Jensen MD. 2013. Fat depots, free fatty acids, and dyslipidemia. Nutrients 5:498–508.
24. Emanuela F, Grazia M, Marco de R, Maria Paola L, Giorgio F, Marco B. 2012. Inflammation as a link between obesity and metabolic syndrome. J Nutr Metab 2012:476380.
25. Engstrom G, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Lohmander LS. 2009. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage 17:168–173.
26. Eymard F, Parsons C, Edwards MH, Petit-Dop F, Reginster JY, Bruyere O, Richette P, Cooper C, Chevalier X. 2015. Diabetes is a risk factor for knee osteoarthritis progression. Osteoarthr Cartilage 23:851–859.
27. Eymard F, Pigenet A, Citadelle D, Flouzat-Lachaniette CH, Poignard A, Benelli C, Berenbaum F, Chevalier X, Houard X. 2014. Induction of an inflammatory and prodegradative phenotype in autologous fibroblast-like synoviocytes by the infrapatellar fat pad from patients with knee osteoarthritis. Arthritis Rheumatol 66:2165–2174.
28. Fantuzzi G. 2005. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919. quiz 920.
29. Favero M, Ramonda R, Goldring MB, Goldring SR, Punzi L. 2015a. Early knee osteoarthritis. RMD open 1:e000062.
30. Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. 1988. Obesity and knee osteoarthritis. The framingham study. Ann Intern Med 109:18–24.
31. Felson DT, Goggins J, Niu J, Zhang Y, Hunter DJ. 2004. The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arthritis Rheum 50:3904–3909.
32. Filkova M, Haluzik M, Gay S, Senolt L. 2009. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol (Orlando, Fla) 133:157–170.
33. Findlay DM. 2007. Vascular pathology and osteoarthritis. Rheumatology (Oxford) 46:1763–1768.
34. Fontanella CG, Carniel EL, Frigo A, Macchi V, Porzionato A, Sarasin G, Rossato M, De Caro R, Natali AN. 2016. Investigation of biomechanical response of Hoffa's fat pad and comparative characterization. J Mech Behav Biomed Mater 67:1–9.
35. Frey MI, Barrett-Connor E, Sledge PA, Schneider DL, Weisman MH. 1996. The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol 23:716–722.
36. Gerber M, Boettner A, Seidel B, Lammert A, Bar J, Schuster E, Thiery J, Kiess W, Kratzsch J. 2005. Serum resistin levels of obese and lean children and adolescents: Biochemical analysis and clinical relevance. J Clin Endocrinol Metab 90:4503–4509.
37. Gierman LM, Wopereis S, van El B, Verheij ER, Werff-van der Vat BJ, Bastiaansen-Jenniskens YM, van Osch GJ, Kloppenburg M, Stojanovic-Susulic V, Huizinga TW, Zuurmond AM. 2013. Metabolic profiling reveals differences in concentrations of oxylipins and fatty acids secreted by the infrapatellar fat pad of donors with end-stage osteoarthritis and normal donors. Arthritis Rheum 65:2606–2614.
38. Grunberg JR, Hammarstedt A, Hedjazifar S, Smith U. 2014. The novel secreted adipokine WNT1-inducible signaling pathway protein 2 (WISP2) is a mesenchymal cell activator of canonical WNT. J Biol Chem 289:6899–6907.
39. Guilak F. 2011. Biomechanical factors in osteoarthritis. Best Pract Res Clin Rheumatol 25:815–823.
40. Han W, Aitken D, Zhu Z, Halliday A, Wang X, Antony B, Cicuttini F. 2015. Signal intensity alteration in the infrapatellar fat pad at baseline for the prediction of knee symptoms and structure in older adults: A cohort study. Ann Rheum Dis 75:1783–1788.
41. Han W, Aitken D, Zhu Z, Halliday A, Wang X, Antony B, Cicuttini F, Jones G, Ding C. 2016. Hypointense signals in the infrapatellar fat pad assessed by magnetic resonance imaging are associated with knee symptoms and structure in older adults: A cohort study. Arthritis Res Ther 18:234.
42. Han W, Cai S, Liu Z, Jin X, Wang X, Antony B, Cao Y, Aitken D, Cicuttini F, Jones G, Ding C. 2014. Infrapatellar fat pad in the knee: Is local fat good or bad for knee osteoarthritis? Arthritis Res Ther 16:R145.
43. Harding GT, Hubley-Kozey CL, Dunbar MJ, Stanish WD, Astephen Wilson JL. 2012. Body mass index affects knee joint mechanics during gait differently with and without moderate knee osteoarthritis. Osteoarthr cartilage 20:1234–1242.
44. Hart DJ, Doyle DV, Spector TD. 1995. Association between metabolic factors and knee osteoarthritis in women: The Chingford study. J Rheumatol 22:1118–1123.
45. Honda K, Ohno S, Tanimoto K, Ijuin C, Tanaka N, Doi T, Kato Y, Tanne K. 2000. The effects of high magnitude cyclic tensile load on cartilage matrix metabolism in cultured chondrocytes. Eur J Cell Biol 79:601–609.
46. Ioan-Facsinay A, Kloppenburg M. 2013. An emerging player in knee osteoarthritis: The infrapatellar fat pad. Arthritis Res Ther 15:225.
47. Ishikawa M, Ito H, Akiyoshi M, Kume N, Yoshitomi H, Mitsuoka H, Tanida S, Murata K, Shibuya H, Kasahara T, Kakino A, Fujita Y, Sawamura T, Yasuda T, Nakamura T. 2012. Lectin-like oxidized low-density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis. Arthritis Rheum 64:1024–1034.
48. Kershaw EE, Flier JS. 2004. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556.
49. Klein-Wieringa IR, de Lange-Brokaar BJ, Yusuf E, Andersen SN, Kwekkeboom JC, Kroon HM, van Osch GJ, Zuurmond AM, Stojanovic-Susulic V, Nelissen RG, Toes RE, Kloppenburg M, Ioan-Facsinay A. 2016. Inflammatory cells in patients with endstage knee osteoarthritis: A comparison between the synovium and the infrapatellar fat pad. J Rheumatol 43:771–778.
50. Klein-Wieringa IR, Kloppenburg M, Bastiaansen-Jenniskens YM, Yusuf E, Kwekkeboom JC, El-Bannoudi H, Nelissen RG, Zuurmond A, Stojanovic-Susulic V, Van Osch GJ, Toes RE, Ioan-Facsinay A. 2011. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann Rheum Dis 70:851–857.
51. Koskinen A, Juslin S, Nieminen R, Moilanen T, Vuolteenaho K, Moilanen E. 2011. Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther 13:R184.
52. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. 2007. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 3:716–724.
53. Lin YY, Tanaka N, Ohkuma S, Iwabuchi Y, Tanne Y, Kamiya T, Kunimatsu R, Huang YC, Yoshioka M, Mitsuyoshi T, Tanimoto K, Tanaka E, Tanne K. 2010. Applying an excessive mechanical stress alters the effect of subchondral osteoblasts on chondrocytes in a co-culture system. Eur J Oral Sci 118:151–158.
54. Lippiello L, Walsh T, Fienhold M. 1991. The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage. Metabolism 40:571–576.
55. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. 2012. Osteoarthritis: A disease of the joint as an organ. Arthritis Rheum 64:1697–1707.
56. Lumeng CN, Bodzin JL, Saltiel AR. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175–184.
57. Macchi V, Porzionato A, Sarasin G, Petrelli L, Guidolin D, Rossato M, Fontanella CG, Natali A, De Caro R. 2016. The infrapatellar adipose body: A histotopographic study. Cells Tissues Organs 201:220–231.
58. Monira Hussain S, Wang Y, Cicuttini FM, Simpson JA, Giles GG, Graves S, Wluka AE. 2014. Incidence of total knee and hip replacement for osteoarthritis in relation to the metabolic syndrome and its components: A prospective cohort study. Semin Arthritis Rheum 43:429–436.
59. Mraz M, Haluzik M. 2014. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 222:R113–R127.
60. Murata M, Yudoh K, Masuko K. 2008. The potential role of vascular endothelial growth factor (VEGF) in cartilage: How the angiogenic factor could be involved in the pathogenesis of osteoarthritis? Osteoarthritis Cartilage 16:279–286.
61. Mutabaruka MS, Aoulad Aissa M, Delalandre A, Lavigne M, Lajeunesse D. 2010. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Res Ther 12:R20.
62. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A, Liu-Bryan R, Glass CK, Neels JG, Olefsky JM. 2007. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 282:35279–35292.
63. Oliviero F, Lo Nigro A, Bernardi D, Giunco S, Baldo G, Scanu A, Sfriso P, Ramonda R, Plebani M, Punzi L. 2012. A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides. Clin Chim Acta 413:303–307.
64. Pan F, Han W, Wang X, Liu Z, Jin X, Antony B, Cicuttini F, Jones G, Ding C. 2015. A longitudinal study of the association between infrapatellar fat pad maximal area and changes in knee symptoms and structure in older adults. Ann Rheum Dis 74:1818–1824.
65. Presle N, Pottie P, Dumond H, Guillaume C, Lapicque F, Pallu S, Mainard D, Netter P, Terlain B. 2006. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage 14:690–695.
66. Rasheed Z, Akhtar N, Haqqi TM. 2011. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-kappaB in human osteoarthritis chondrocytes. Rheumatology (Oxford) 50:838–851.
67. Rastelli F, Capodaglio P, Orgiu S, Santovito C, Caramenti M, Cadioli M, Falini A, Rizzo G, Lafortuna CL. 2015. Effects of muscle composition and architecture on specific strength in obese older women. Exp Physiol 100:1159–1167.
68. Richter M, Trzeciak T, Owecki M, Pucher A, Kaczmarczyk J. 2015. The role of adipocytokines in the pathogenesis of knee joint osteoarthritis. Int Orthop 39:1211–1217.
69. Rosa SC, Goncalves J, Judas F, Mobasheri A, Lopes C, Mendes AF. 2009. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther 11:R80.
70. Rosa SC, Rufino AT, Judas FM, Tenreiro CM, Lopes MC, Mendes AF. 2011. Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes. J Cell Biochem 112:2813–2824.
71. Sanchez C, Pesesse L, Gabay O, Delcour JP, Msika P, Baudouin C, Henrotin YE. 2012. Regulation of subchondral bone osteoblast metabolism by cyclic compression. Arthritis Rheum 64:1193–1203.
72. Santangelo KS, Radakovich LB, Fouts J, Foster MT. 2016. Pathophysiology of obesity on knee joint homeostasis: Contributions of the infrapatellar fat pad. Horm Mol Biol Clin Investig 26:97–108.
73. Schett G, Kleyer A, Perricone C, Sahinbegovic E, Iagnocco A, Zwerina J, Lorenzini R, Aschenbrenner F, Berenbaum F, D'Agostino MA, Willeit J, Kiechl S. 2013. Diabetes is an independent predictor for severe osteoarthritis: Results from a longitudinal cohort study. Diabetes Care 36:403–409.
74. Sellam J, Berenbaum F. 2010. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 6:625–635.
75. Shakoor N, Foucher KC, Wimmer MA, Mikolaitis-Preuss RA, Fogg LF, Block JA. 2014. Asymmetries and relationships between dynamic loading, muscle strength, and proprioceptive acuity at the knees in symptomatic unilateral hip osteoarthritis. Arthritis Res Ther 16:455.
76. Simopoulou T, Malizos KN, Tsezou A. 2007. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human articular chondrocytes. Clin Exp Rheumatol 25:605–612.
77. Soran N, Altindag O, Cakir H, Celik H, Demirkol A, Aksoy N. 2008. Assessment of paraoxonase activities in patients with knee osteoarthritis. Redox Rep 13:194–198.
78. Sowers MR, Karvonen-Gutierrez CA. 2010. The evolving role of obesity in knee osteoarthritis. Curr Opin Rheumatol 22:533–537.
79. Tiku ML, Shah R, Allison GT. 2000. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 275:20069–20076.
80. Tong KM, Shieh DC, Chen CP, Tzeng CY, Wang SP, Huang KC, Chiu YC, Fong YC, Tang CH. 2008. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts. Cell Signal 20:1478–1488.
81. Triantaphyllidou IE, Kalyvioti E, Karavia E, Lilis I, Kypreos KE, Papachristou DJ. 2013. Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet. Osteoarthr Cartilage 21:322–330.
82. Tsezou A, Iliopoulos D, Malizos KN, Simopoulou T. 2010. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. J Orthop Res 28:1033–1039.
83. Ushiyama T, Chano T, Inoue K, Matsusue Y. 2003. Cytokine production in the infrapatellar fat pad: Another source of cytokines in knee synovial fluids. Ann Rheum Dis 62:108–112.
84. Verzijl N, DeGroot J, Ben ZC, Brau-Benjamin O, Maroudas A, Bank RA, Mizrahi J, Schalkwijk CG, Thorpe SR, Baynes JW, Bijlsma JW, Lafeber FP, TeKoppele JM. 2002. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: A possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 46:114–123.
85. Visser AW, de Mutsert R, le Cessie S, den Heijer M, Rosendaal FR, Kloppenburg M. 2015. The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis: The NEO study. Ann Rheum Dis 74:1842–1847.
86. Vuolteenaho K, Koskinen A, Kukkonen M, Nieminen R, Paivarinta U, Moilanen T, Moilanen E. 2009. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage-mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediators Inflamm 2009:345838.
87. Wang K, Xu J, Cai J, Zheng S, Han W, Antony B, Ding C. 2016a. Serum levels of interleukin-17 and adiponectin are associated with infrapatellar fat pad volume and signal intensity alteration in patients with knee osteoarthritis. Arthritis Res Ther 18:193.
88. Wang K, Xu J, Cai J, Zheng S, Yang X, Ding C. 2016b. Serum levels of resistin and interleukin-17 are associated with increased cartilage defects and bone marrow lesions in patients with knee osteoarthritis. Mod Rheumatol 11:1–6.
89. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808.
90. White L, Holyoak R, Sant J, Hartnell N, Mullan J. 2016. The effect of infrapatellar fat pad resection on outcomes post-total knee arthroplasty: A systematic review. Arch Orthop Trauma Surg 136:701–708.
91. White LD, Melhuish TM. 2016. The role of infrapatellar fat pad resection in total knee arthroplasty. Ann Rheum Dis 75:e66.
92. WHO. 2008. Raised cholesterol. http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/#
93. Williams MF, London DA, Husni EM, Navaneethan S, Kashyap SR. 2016. Type 2 diabetes and osteoarthritis: A systematic review and meta-analysis. J Diabetes Complications 30:944–950.
94. Yang CZ, Zhang YY, Zheng M. 2011. Soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in synovial fluid are correlated with disease severity of knee osteoarthritis. Clin Biochem 44:1094–1096.
95. Yang WH, Liu SC, Tsai CH, Fong YC, Wang SJ, Chang YS, Tang CH. 2013. Leptin induces IL-6 expression through OBRl receptor signaling pathway in human synovial fibroblasts. PLoS ONE 8:e75551.
96. Ye C, Zhang W, Wu W, Xu M, Nonso NS, He R. 2016. Influence of the infrapatellar fat pad resection during total knee arthroplasty: A systematic review and meta-analysis. PLoS ONE 11:0163515.
97. Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O. 1998. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J 334:9–13.
98. Yoshimura N, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, Akune T. 2012. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: A 3-year follow-up of the ROAD study. Osteoarthr Cartilage 20:1217–1226.
99. Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, Herrero-Beaumont G, Kirschner S, Leeb BF, Lohmander LS, Mazieres B, Pavelka K, Punzi L, So AK, Tuncer T, Watt I, Bijlsma JW. 2010. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis 69:483–489.
100. Zhang Y, Jordan JM. 2010. Epidemiology of osteoarthritis. Clin Geriatr Med 26:355–369.